{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:44Z","timestamp":1792684664001,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T00:00:00Z","timestamp":1326067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/nrmicro2712","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T09:48:04Z","timestamp":1326102484000},"page":"150-156","source":"Crossref","is-referenced-by-count":149,"title":["Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none"],"prefix":"10.1038","volume":"10","author":[{"given":"Daniel L.","family":"Barber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno B.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Sereti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,9]]},"reference":[{"key":"BFnrmicro2712_CR1","doi-asserted-by":"publisher","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","volume":"4","author":"A Zolopa","year":"2009","unstructured":"Zolopa, A. et al. Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 4, e5575 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrmicro2712_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"SS Abdool Karim","year":"2010","unstructured":"Abdool Karim, S. S. et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N. Engl. J. Med. 362, 697\u2013706 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1086\/605500","volume":"49","author":"B Castelnuovo","year":"2009","unstructured":"Castelnuovo, B. et al. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban african cohort. Clin. Infect. Dis. 49, 965\u2013972 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR4","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","volume":"365","author":"SS Abdool Karim","year":"2011","unstructured":"Abdool Karim, S. S. et al. Integration of antiretroviral therapy with tuberculosis treatment. N. Engl. J. Med. 365, 1492\u20131501 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR5","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/j.ijid.2011.02.007","volume":"15","author":"I Hoyo-Ulloa","year":"2011","unstructured":"Hoyo-Ulloa, I. et al. Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico. Int. J. Infect. Dis. 15, e408\u2013e414 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"BFnrmicro2712_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"F-X Blanc","year":"2011","unstructured":"Blanc, F.-X. et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N. Engl. J. Med. 365, 1471\u20131481 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR7","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"DV Havlir","year":"2011","unstructured":"Havlir, D. V. et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N. Engl. J. Med. 365, 1482\u20131491 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","volume":"1","author":"MA French","year":"2000","unstructured":"French, M. A. et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 1, 107\u2013115 (2000).","journal-title":"HIV Med."},{"key":"BFnrmicro2712_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1086\/499356","volume":"42","author":"I Ratnam","year":"2006","unstructured":"Ratnam, I., Chiu, C., Kandala, N.-B. & Easterbrook, P. J. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin. Infect. Dis. 42, 418\u2013427 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","volume":"22","author":"DM Murdoch","year":"2008","unstructured":"Murdoch, D. M., Venter, W. D. F., Feldman, C. & Van Rie, A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22, 601\u2013610 (2008).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR11","doi-asserted-by":"publisher","first-page":"e11416","DOI":"10.1371\/journal.pone.0011416","volume":"5","author":"PM Grant","year":"2010","unstructured":"Grant, P. M. et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE 5, e11416 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrmicro2712_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.aids.0000199014.66139.39","volume":"20","author":"G Breton","year":"2006","unstructured":"Breton, G. et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20, 119\u2013121 (2006).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/374603","volume":"36","author":"RC Nolan","year":"2003","unstructured":"Nolan, R. C., Chidlow, G. & French, M. A. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection. Clin. Infect. Dis. 36, 1191\u20131194 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR14","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1086\/426078","volume":"39","author":"E Connick","year":"2004","unstructured":"Connick, E., Kane, M. A., White, I. E., Ryder, J. & Campbell, T. B. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin. Infect. Dis. 39, 1852\u20131855 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","volume":"10","author":"M Mueller","year":"2010","unstructured":"Mueller, M. et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 251\u2013261 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrmicro2712_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","volume":"46","author":"YC Manabe","year":"2007","unstructured":"Manabe, Y. C., Campbell, J. D., Sydnor, E. & Moore, R. D. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J. Acquir. Immune Defic. Syndr. 46, 456\u2013462 (2007).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrmicro2712_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","volume":"8","author":"G Meintjes","year":"2008","unstructured":"Meintjes, G. et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect. Dis. 8, 516\u2013523 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrmicro2712_CR18","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/01.aids.0000202648.18526.bf","volume":"20","author":"A Bourgarit","year":"2006","unstructured":"Bourgarit, A. et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20, F1\u2013F7 (2006).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR19","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.4049\/jimmunol.0804020","volume":"183","author":"A Bourgarit","year":"2009","unstructured":"Bourgarit, A. et al. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative \u03b3\u03b4 T cells. J. Immunol. 183, 3915\u20133923 (2009).","journal-title":"J. Immunol."},{"key":"BFnrmicro2712_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1164\/rccm.200806-858OC","volume":"178","author":"G Meintjes","year":"2008","unstructured":"Meintjes, G. et al. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med. 178, 1083\u20131089 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrmicro2712_CR21","first-page":"1173","volume":"136","author":"JB Roths","year":"1990","unstructured":"Roths, J. B., Marshall, J. D., Allen, R. D., Carlson, G. A. & Sidman, C. L. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology. Am. J. Pathol. 136, 1173\u20131186 (1990).","journal-title":"Am. J. Pathol."},{"key":"BFnrmicro2712_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1172\/JCI115910","volume":"90","author":"JB Roths","year":"1992","unstructured":"Roths, J. B. & Sidman, C. L. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J. Clin. Invest. 90, 673\u2013678 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFnrmicro2712_CR23","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/IAI.61.5.1641-1649.1993","volume":"61","author":"JB Roths","year":"1993","unstructured":"Roths, J. B. & Sidman, C. L. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect. Immun. 61, 1641\u20131649 (1993).","journal-title":"Infect. Immun."},{"key":"BFnrmicro2712_CR24","doi-asserted-by":"publisher","first-page":"L1256","DOI":"10.1152\/ajplung.00079.2006","volume":"291","author":"F Gigliotti","year":"2006","unstructured":"Gigliotti, F., Xu, H. & Wright, T. Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L1256\u2013L1266 (2006).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrmicro2712_CR25","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.4049\/jimmunol.0802775","volume":"182","author":"EN Atochina-Vasserman","year":"2009","unstructured":"Atochina-Vasserman, E. N. et al. Immune reconstitution during pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J. Immunol. 182, 2277\u20132287 (2009).","journal-title":"J. Immunol."},{"key":"BFnrmicro2712_CR26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/00002030-199211000-00009","volume":"6","author":"MA French","year":"1992","unstructured":"French, M. A., Mallal, S. A. & Dawkins, R. L. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 6, 1293\u20131297 (1992).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR27","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1182\/blood-2010-05-286336","volume":"116","author":"DL Barber","year":"2010","unstructured":"Barber, D. L. et al. Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 116, 3485\u20133493 (2010).","journal-title":"Blood"},{"key":"BFnrmicro2712_CR28","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1086\/644784","volume":"200","author":"JH Elliott","year":"2009","unstructured":"Elliott, J. H. et al. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J. Infect. Dis. 200, 1736\u20131745 (2009).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2712_CR29","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2010-05-285080","volume":"116","author":"LRV Antonelli","year":"2010","unstructured":"Antonelli, L. R. V. et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 116, 3818\u20133827 (2010).","journal-title":"Blood"},{"key":"BFnrmicro2712_CR30","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/QAD.0b013e328348fb18","volume":"25","author":"DBA Tan","year":"2011","unstructured":"Tan, D. B. A. et al. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 25, 1455\u20131460 (2011).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2006.04.569","volume":"120","author":"T Krupica","year":"2006","unstructured":"Krupica, T., Fry, T. J. & Mackall, C. L. Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 120, 121\u2013128 (2006).","journal-title":"Clin. Immunol."},{"key":"BFnrmicro2712_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ni.2018","volume":"131","author":"J Sprent","year":"2011","unstructured":"Sprent, J. & Surh, C. D. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nature Immunol. 131, 478\u2013484 (2011).","journal-title":"Nature Immunol."},{"key":"BFnrmicro2712_CR33","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.4049\/jimmunol.177.7.4521","volume":"177","author":"IE Brown","year":"2006","unstructured":"Brown, I. E., Blank, C., Kline, J., Kacha, A. K. & Gajewski, T. F. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J. Immunol. 177, 4521\u20134529 (2006).","journal-title":"J. Immunol."},{"key":"BFnrmicro2712_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King, C., Ilic, A., Koelsch, K. & Sarvetnick, N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117, 265\u2013277 (2004).","journal-title":"Cell"},{"key":"BFnrmicro2712_CR35","doi-asserted-by":"publisher","first-page":"8732","DOI":"10.1073\/pnas.161126098","volume":"98","author":"JT Tan","year":"2001","unstructured":"Tan, J. T. et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl Acad. Sci. USA 98, 8732\u20138737 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2712_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/80868","volume":"1","author":"KS Schluns","year":"2000","unstructured":"Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefran\u00e7ois, L. Interleukin-7 mediates the homeostasis of na\u00efve and memory CD8 T cells in vivo. Nature Immunol. 1, 426\u2013432 (2000).","journal-title":"Nature Immunol."},{"key":"BFnrmicro2712_CR37","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.4049\/jimmunol.174.6.3158","volume":"174","author":"WC Kieper","year":"2005","unstructured":"Kieper, W. C. et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J. Immunol. 174, 3158\u20133163 (2005).","journal-title":"J. Immunol."},{"key":"BFnrmicro2712_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane, J. et al. Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent. N. Engl. J. Med. 345, 1098\u20131104 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/598504","volume":"48","author":"RS Wallis","year":"2009","unstructured":"Wallis, R. S., van Vuuren, C. & Potgieter, S. Adalimumab treatment of life-threatening tuberculosis. Clin. Infect. Dis. 48, 1429\u20131432 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR40","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1186\/1752-1947-3-6673","volume":"3","author":"YK Yoon","year":"2009","unstructured":"Yoon, Y. K. et al. Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report. J. Med. Case Rep. 3, 6673 (2009).","journal-title":"J. Med. Case Rep."},{"key":"BFnrmicro2712_CR41","first-page":"1057","volume":"9","author":"R Belknap","year":"2005","unstructured":"Belknap, R., Reves, R. & Burman, W. Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab. Int. J. Tuberc. Lung Dis. 9, 1057\u20131058 (2005).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"BFnrmicro2712_CR42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1086\/522993","volume":"45","author":"SM Arend","year":"2007","unstructured":"Arend, S. M., Leyten, E. M. S., Franken, W. P. J., Huisman, E. M. & van Dissel, J. T. A patient with de novo tuberculosis during anti-tumor necrosis factor-\u03b1 therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin. Infect. Dis. 45, 1470\u20131475 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/RHU.0b013e3181bc9407","volume":"15","author":"A Szerszen","year":"2009","unstructured":"Szerszen, A., Gupta, S., Seminara, D., Jarrett, M. & Goldstein, M. Peritoneal tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient treated with infliximab?: a case for adjuvant immunosuppressive therapy. J. Clin. Rheumatol. 15, 417\u2013418 (2009).","journal-title":"J. Clin. Rheumatol."},{"key":"BFnrmicro2712_CR44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1086\/427941","volume":"40","author":"C Garcia Vidal","year":"2005","unstructured":"Garcia Vidal, C. et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin. Infect. Dis. 40, 756\u2013759 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jbspin.2011.01.003","volume":"78","author":"C Rivoisy","year":"2011","unstructured":"Rivoisy, C., Amrouche, L., Carcelain, G., Sereni, D. & Bourgarit, A. Paradoxical exacerbation of tuberculosis after TNF\u03b1 antagonist discontinuation: beware of immune reconstitution inflammatory syndrome. Joint Bone Spine 78, 312\u2013315 (2011).","journal-title":"Joint Bone Spine"},{"key":"BFnrmicro2712_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","volume":"72","author":"BO Khatri","year":"2009","unstructured":"Khatri, B. O. et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72, 402\u2013409 (2009).","journal-title":"Neurology"},{"key":"BFnrmicro2712_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"Clifford, D. B. et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 9, 438\u2013446 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnrmicro2712_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/WCO.0b013e328346be57","volume":"24","author":"T Johnson","year":"2011","unstructured":"Johnson, T. & Nath, A. Immune reconstitution inflammatory syndrome and the central nervous system. Curr. Opin. Neurol. 24, 284\u2013290 (2011).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrmicro2712_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"G Van Assche","year":"2005","unstructured":"Van Assche, G. et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 353, 362\u2013368 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR50","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJMoa0810316","volume":"361","author":"H Lind\u00e5","year":"2009","unstructured":"Lind\u00e5, H. et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N. Engl. J. Med. 361, 1081\u20131087 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2712_CR51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ana.22137","volume":"68","author":"CF Ryschkewitsch","year":"2010","unstructured":"Ryschkewitsch, C. F. et al. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 68, 384\u2013391 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrmicro2712_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archneurol.2010.257","volume":"68","author":"A Miravalle","year":"2011","unstructured":"Miravalle, A., Jensen, R. & Kinkel, R. P. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch. Neurol. 68, 186\u2013191 (2011).","journal-title":"Arch. Neurol."},{"key":"BFnrmicro2712_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cid\/cir276","volume":"53","author":"HY Sun","year":"2011","unstructured":"Sun, H. Y. & Singh, N. Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. Clin. Infect. Dis. 53, 168\u2013176 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1399-3062.2010.00592.x","volume":"13","author":"T Legris","year":"2011","unstructured":"Legris, T. et al. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient. Transpl. Infect. Dis. 13, 303\u2013308 (2011).","journal-title":"Transpl. Infect. Dis."},{"key":"BFnrmicro2712_CR55","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1086\/430606","volume":"40","author":"N Singh","year":"2005","unstructured":"Singh, N. et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin. Infect. Dis. 40, 1756\u20131761 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR56","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/lt.21601","volume":"14","author":"G Crespo","year":"2008","unstructured":"Crespo, G. et al. Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient. Liver Transpl. 14, 1671\u20131674 (2008).","journal-title":"Liver Transpl."},{"key":"BFnrmicro2712_CR57","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1111\/j.1600-6143.2007.01994.x","volume":"7","author":"F Lanternier","year":"2007","unstructured":"Lanternier, F. et al. Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am. J. Transplant. 7, 2826\u20132828 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrmicro2712_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10096-008-0461-2","volume":"27","author":"N Singh","year":"2008","unstructured":"Singh, N. Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses. Eur. J. Clin. Microbiol. Infect. Dis. 27, 403\u2013408 (2008).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"BFnrmicro2712_CR59","doi-asserted-by":"publisher","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","volume":"7","author":"DR Boulware","year":"2010","unstructured":"Boulware, D. R. et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 7, e1000384 (2010).","journal-title":"PLoS Med."},{"key":"BFnrmicro2712_CR60","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/655785","volume":"202","author":"DR Boulware","year":"2010","unstructured":"Boulware, D. R. et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J. Infect. Dis. 202, 962\u2013970 (2010).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2712_CR61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nm.2142","volume":"16","author":"TM Strutt","year":"2010","unstructured":"Strutt, T. M. et al. Memory CD4+ T cells induce innate responses independently of pathogen. Nature Med. 16, 558\u2013564 (2010).","journal-title":"Nature Med."},{"key":"BFnrmicro2712_CR62","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.4049\/jimmunol.1003304","volume":"186","author":"DL Barber","year":"2011","unstructured":"Barber, D. L., Mayer-Barber, K. D., Feng, C. G., Sharpe, A. H. & Sher, A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 186, 1598\u20131607 (2011).","journal-title":"J. Immunol."},{"key":"BFnrmicro2712_CR63","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1183\/09031936.00091010","volume":"37","author":"R Tadokera","year":"2011","unstructured":"Tadokera, R. et al. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur. Respir. J. 37, 1248\u20131259 (2011).","journal-title":"Eur. Respir. J."},{"key":"BFnrmicro2712_CR64","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/infdis\/jir134","volume":"203","author":"DR Boulware","year":"2011","unstructured":"Boulware, D. R. et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J. Infect. Dis. 203, 1637\u20131646 (2011).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2712_CR65","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1086\/657082","volume":"202","author":"BG Oliver","year":"2010","unstructured":"Oliver, B. G. et al. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J. Infect. Dis. 202, 1728\u20131737 (2010).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2712_CR66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/QAD.0b013e32831d2a98","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn, S. D., Wainwright, H. & Orrell, C. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 23, 143\u2013145 (2009).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","volume":"21","author":"SD Lawn","year":"2007","unstructured":"Lawn, S. D., Myer, L., Bekker, L.-G. & Wood, R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21, 335\u2013341 (2007).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR68","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents, US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescencents, 10 Jan 2011. AIDSinfo [online] (2011)."},{"key":"BFnrmicro2712_CR69","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/cid\/cir230","volume":"52","author":"ME T\u00f6r\u00f6k","year":"2011","unstructured":"T\u00f6r\u00f6k, M. E. et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis. Clin. Infect. Dis. 52, 1374\u20131383 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro2712_CR70","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","volume":"24","author":"G Meintjes","year":"2010","unstructured":"Meintjes, G. et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 24, 2381\u20132390 (2010).","journal-title":"AIDS"},{"key":"BFnrmicro2712_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/595006","volume":"48","author":"MA French","year":"2009","unstructured":"French, M. A. Immune reconstitution inflammatory syndrome: a reappraisal. Clin. Infect. Dis. 48, 101\u2013107 (2009).","journal-title":"Clin. Infect. Dis."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2712","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:32:52Z","timestamp":1684456372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,9]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFnrmicro2712"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro2712","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,9]]}}}